-
-
-
-
-
-
-
Progenics Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update
-
-
-
-
-
-
-
Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2017 Financial Results and Business Update
-
-
-
-
-
-
-
Progenics Pharma (PGNX) Reports FDA Acceptance of New Drug Application for AZEDRA (iobenguane I 131) in Pheochromocytoma and Paraganglioma
-
-
-
-
-
-
-
Progenics' (PGNX) Relistor Setback Only a Speedbump - Jefferies
-
-
-
-
-
-
-
Color From Progenics (PGNX) Management Meeting - Jefferies
-
-
15,474 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

